JPH0133480B2 - - Google Patents

Info

Publication number
JPH0133480B2
JPH0133480B2 JP53006261A JP626178A JPH0133480B2 JP H0133480 B2 JPH0133480 B2 JP H0133480B2 JP 53006261 A JP53006261 A JP 53006261A JP 626178 A JP626178 A JP 626178A JP H0133480 B2 JPH0133480 B2 JP H0133480B2
Authority
JP
Japan
Prior art keywords
leu
ala
amino acid
peptide
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53006261A
Other languages
English (en)
Japanese (ja)
Other versions
JPS53111014A (en
Inventor
Daburyu Erikuson Buruusu
Ii Hyuuri Tonii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of JPS53111014A publication Critical patent/JPS53111014A/ja
Publication of JPH0133480B2 publication Critical patent/JPH0133480B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP626178A 1977-01-25 1978-01-25 Synthetic peptide Granted JPS53111014A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76242777A 1977-01-25 1977-01-25
US87071378A 1978-01-19 1978-01-19

Publications (2)

Publication Number Publication Date
JPS53111014A JPS53111014A (en) 1978-09-28
JPH0133480B2 true JPH0133480B2 (OSRAM) 1989-07-13

Family

ID=27117118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP626178A Granted JPS53111014A (en) 1977-01-25 1978-01-25 Synthetic peptide

Country Status (5)

Country Link
JP (1) JPS53111014A (OSRAM)
CH (1) CH637628A5 (OSRAM)
DE (1) DE2803238A1 (OSRAM)
FR (1) FR2377998A1 (OSRAM)
GB (1) GB1568195A (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE94562T1 (de) * 1987-10-23 1993-10-15 Progen Biotechnik Gmbh Antigene peptide des komplementfaktors c3a, verwendung der peptide, zell-linien, antikoerper gegen die peptide und verwendung der antikoerper.

Also Published As

Publication number Publication date
FR2377998A1 (fr) 1978-08-18
GB1568195A (en) 1980-05-29
DE2803238A1 (de) 1978-08-03
CH637628A5 (en) 1983-08-15
JPS53111014A (en) 1978-09-28
FR2377998B1 (OSRAM) 1980-08-29

Similar Documents

Publication Publication Date Title
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
HU181009B (en) Process for preparing angiotensin-ii analogues with antagonictic activity containing in position 1 sarcosyl,hydroxyacetyl or l-alpha-aminoxy-propionyl group and in positiona 8 esteric group
JP2008543884A (ja) ビバリルジンの生成方法
JPS602318B2 (ja) アレルギー反応遮断ポリペプチド剤
CN104350065B (zh) V1a受体激动剂
US4438029A (en) Synthetic peptides
JPWO1992004374A1 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
US5393740A (en) Neurotensin Hexapeptides
JP4414503B2 (ja) オリゴペプチドの１工程塩変換および精製方法
CN101190942B (zh) 具有溶血栓活性的化合物、其制备方法和应用
KR0171614B1 (ko) 혈관활성 바소토신 유도체
EP0570428A1 (en) FACTOR IIa INHIBITORS
JPS5959654A (ja) ホルモン放出因子類似体及びその製造方法
CN104277113B (zh) 抑制hiv感染的二价多肽
WO1995024421A1 (en) Peptide derivative
CN102060908B (zh) 一种人工合成的新型抗血栓多肽及其制备方法和应用
ZHAO et al. Synthesis and activity of partial retro‐inverso analogs of the antimetastatic laminin‐derived peptide, YIGSR‐NH2
JP2001278893A (ja) 新規ペプチド、その製造法及び用途
CN102153623B (zh) 具有溶血栓活性的化合物、其制备方法和应用
CA1154757A (en) Synthetic peptides
JPH047360B2 (OSRAM)
GB1568195A (en) Synthetc peptides
JP2640778B2 (ja) ペプチドおよびこれを含有する抗痴呆剤
JP2922247B2 (ja) アンギオテンシン変換酵素阻害剤
JPH07316193A (ja) ペプチド誘導体およびその用途